Agilent to Construct Manufacturing Facility in Colorado

Agilent Technologies Inc. has bought land in Frederick, CO to construct a new manufacturing facility that the company said will “more than double” its production capacity for nucleic acid active pharmaceutical ingredients, the Santa Clara, CA-based company announced Tuesday.

“The products manufactured at this site will be used by our customers to improve the lives of patients suffering from a variety of diseases,” Skip Thune, general manager of Agilent’s Nicleic Acids Solutions division in a press release. “At Agilent, we are committed to meeting the ever-increasing needs of our customers for oligonucleotides.”

The facility on the 20-acre site in Weld County will provide about 150 to 200 new, permanent jobs.

“Colorado is thrilled to welcome Agilent Technologies to the state,” said Gov. John Hickenlooper, quoted in the company’s press release, “This expansion will enhance Colorado’s skilled workforce and dedication to research and development firms. We look forward to supporting Agilent’s innovative work in our state.”

The company’s release noted that researchers are investigating oligonucleotides’ efficacy in treating some forms of cancer, diabetes, muscular dystrophy, and other disorders.